ARDX
Price
$5.02
Change
+$0.17 (+3.51%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.2B
6 days until earnings call
HRTX
Price
$2.27
Change
+$0.07 (+3.18%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
345.79M
17 days until earnings call
Ad is loading...

ARDX vs HRTX

Header iconARDX vs HRTX Comparison
Open Charts ARDX vs HRTXBanner chart's image
Ardelyx
Price$5.02
Change+$0.17 (+3.51%)
Volume$106.62K
Capitalization1.2B
Heron Therapeutics
Price$2.27
Change+$0.07 (+3.18%)
Volume$10.33K
Capitalization345.79M
ARDX vs HRTX Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. HRTX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a StrongBuy and HRTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ARDX: $4.84 vs. HRTX: $2.20)
Brand notoriety: ARDX and HRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 91% vs. HRTX: 74%
Market capitalization -- ARDX: $1.15B vs. HRTX: $335.13M
ARDX [@Biotechnology] is valued at $1.15B. HRTX’s [@Biotechnology] market capitalization is $335.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARDX and HRTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish while HRTX’s TA Score has 7 bullish TA indicator(s).

  • ARDX’s TA Score: 5 bullish, 4 bearish.
  • HRTX’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а +5.11% price change this week, while HRTX (@Biotechnology) price change was +19.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ARDX is expected to report earnings on Jul 31, 2025.

HRTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.2B) has a higher market cap than HRTX($346M). HRTX YTD gains are higher at: 48.366 vs. ARDX (-4.635). HRTX has higher annual earnings (EBITDA): -5.06M vs. ARDX (-16.71M). ARDX has more cash in the bank: 250M vs. HRTX (59.3M). ARDX has less debt than HRTX: ARDX (153M) vs HRTX (178M). ARDX has higher revenues than HRTX: ARDX (334M) vs HRTX (144M).
ARDXHRTXARDX / HRTX
Capitalization1.2B346M346%
EBITDA-16.71M-5.06M331%
Gain YTD-4.63548.366-10%
P/E RatioN/AN/A-
Revenue334M144M232%
Total Cash250M59.3M422%
Total Debt153M178M86%
FUNDAMENTALS RATINGS
ARDX vs HRTX: Fundamental Ratings
ARDX
HRTX
OUTLOOK RATING
1..100
1111
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
7546
P/E GROWTH RATING
1..100
40100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (70) in the Biotechnology industry is in the same range as ARDX (98). This means that HRTX’s stock grew similarly to ARDX’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARDX (100). This means that HRTX’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's SMR Rating (92) in the Biotechnology industry is in the same range as HRTX (100). This means that ARDX’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (46) in the Biotechnology industry is in the same range as ARDX (75). This means that HRTX’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's P/E Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for HRTX (100). This means that ARDX’s stock grew somewhat faster than HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXHRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMECX10.09N/A
N/A
Ashmore Emerging Markets Equity C
JEMWX30.70N/A
N/A
JPMorgan Emerging Markets Equity R6
MSCQX9.81N/A
N/A
Mercer US Small/Mid Cap Equity I
JFACX31.98N/A
N/A
JHancock Fundamental All Cap Core R2
BGGKX23.49N/A
N/A
Baillie Gifford US Equity Growth K

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
+0.52%
VCYT - ARDX
45%
Loosely correlated
+1.08%
HRTX - ARDX
41%
Loosely correlated
+2.33%
RNAC - ARDX
37%
Loosely correlated
+3.37%
PCVX - ARDX
35%
Loosely correlated
+5.95%
DRTS - ARDX
33%
Loosely correlated
+1.91%
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+3.18%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
+7.92%
ACAD - HRTX
43%
Loosely correlated
+1.44%
SYRE - HRTX
39%
Loosely correlated
+4.99%
ABSI - HRTX
39%
Loosely correlated
+0.94%
More